ID
24570
Beskrivning
Study ID: 100470 Clinical Study ID: SCO100470 Study Title: A multicentre, randomised, double-blind, parallel group, 24 week study to compare the effect of salmeterol/fluticasone propionate combination product 50/250mcg, with salmeterol 50mcg both delivered twice daily via DISKUS®/ACCUHALER® inhaler on lung function and dyspnoea in subjects with Chronic Obstructive Pulmonary Disease (COPD). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: fluticasone propionate/salmeterol Trade Name: Serevent Study Indication: Pulmonary Disease, Chronic Obstructive
Nyckelord
Versioner (1)
- 2017-08-06 2017-08-06 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
6 augusti 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
Beskrivning
If "yes" to COPD exacerbation, record following items.
Alias
- UMLS CUI-1
- C0740304
Beskrivning
date of onset of COPD exacerbation
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0574845
- UMLS CUI [1,2]
- C0740304
Beskrivning
outcome of COPD exacerbation
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0085565
- UMLS CUI [1,2]
- C0740304
Beskrivning
date of resolution or death
Datatyp
date
Alias
- UMLS CUI [1]
- C2985858
- UMLS CUI [2]
- C1148348
Beskrivning
severity of COPD excerbation
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0439793
- UMLS CUI [1,2]
- C0740304
Beskrivning
Subjects who experience more than one moderate exacerbation requiring antibiotic and/or oral corticosteroid treatment during the treatment period and/or experience a severe exacerbation requiring hospitalisation during the course of the study must be withdrawn.
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0422727
- UMLS CUI [1,2]
- C0740304
Similar models
COPD excerbation salmeterol/fluticasone propionate combination compared to salmeterol on COPD 100470
C0740304 (UMLS CUI [1,2])
C0740304 (UMLS CUI [1,2])
C1148348 (UMLS CUI [2])
C0740304 (UMLS CUI [1,2])
C0740304 (UMLS CUI [1,2])